Clinical Trial

Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform

Study acronym: TARGET-RCC
Recruiting
View on ClinicalTrials.gov →
Summary
This project aims to provide an accurate strategy to guide the decision making relying on tumor biopsies using standard histology, immunohistochemistry (IHC), spatial transcriptomics, genomics combined with Magnetic Resonance Imaging (MRI) and radiomics. Moreover, the investigators will explore potential markers indicative of response to systemic agents or ablative therapy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-04; most recent amendment 2026-03-16.
Status change: Not Yet Recruiting → Recruiting 2026-03-16
Trial Details
NCT Number NCT06868927
Lead Sponsor IRCCS San Raffaele
Conditions Renal Tumors
Enrollment 50 participants
Start Date 2025-09-26
Primary Completion 2029-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-17